Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma
Abstract
MicroRNAs are short regulatory RNAs that negatively modulate gene expression at the post-transcriptional level, and are deeply involved in the pathogenesis of several types of cancers. To investigate whether specific miRNAs and their target genes participate in the molecular pathogenesis of laryngeal carcinoma, oligonucleotide microarrays were used to assess the differential expression profiles of microRNAs and mRNAs in laryngeal carcinoma tissues compared with normal tissues. The oncogenic miRNA, microRNA-21 (miR-21), was found to be upregulated in laryngeal carcinoma tissues. Knockdown of miR-21 by specific antisense oligonucleotides inhibited the proliferation potential of HEp-2 cells, whereas overexpression of miR-21 elevated growth activity of the cells, as detected by the colony formation assay. The cell number reduction caused by miR-21 inhibition was due to the loss of control of the G1-S phase transition, instead of a noticeable increase in apoptosis. Subsequently, a new target gene of miR-21, BTG2, was found to be downregulated in laryngeal carcinoma tissues. BTG2 is known to act as a pan-cell cycle regulator and tumor suppressor. These findings indicate that aberrant expression of miR-21 may contribute to the malignant phenotype of laryngeal carcinoma by maintaining a low level of BTG2. The identification of the oncogenic miR-21 and its target gene, BTG2, in laryngeal carcinoma is potentially valuable for cancer diagnosis and therapy.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In laryngeal carcinoma, miR-21 targets BTG2, a p53 target gene, recently shown to suppress oncogenic Ras activity by reducing the GTP bound, active state.
“In laryngeal carcinoma, miR-21 targets BTG2 (Liu et al., 2009), a p53 target gene, recently shown to suppress oncogenic Ras activity by reducing the GTP bound, active state (Buganim et al., 2010).”
From Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21 (2010) · cites this paper as Liu et al., 2009
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714 · see citing works
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855 · see citing works
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1997 · Cited by 7,592 · see citing works
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755 · see citing works
Combinatorial microRNA target predictions
Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603 · see citing works
Prediction of Mammalian MicroRNA Targets
Lewis, B. P., Shih, I.-H., Jones-Rhoades, M. W., Bartel, D. P., & Burge, C. B. (2003) · Cell · doi:10.1016/s0092-8674(03)01018-3 · Cited by 4,333 · see citing works
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053 · see citing works
MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer
Meng, F., Henson, R., Wehbe–Janek, H., Ghoshal, K., Jacob, S. T., & Patel, T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.022 · Cited by 2,773 · see citing works
MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells
Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557 · see citing works
Asangani, I. A., Rasheed, S. A. K., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., & Allgayer, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210856 · Cited by 1,882 · see citing works
Si, M.-L., Zhu, S., Wu, H., Lu, Z., Wu, F., & Mo, Y.-Y. (2007) · Oncogene · doi:10.1038/sj.onc.1210083 · Cited by 1,600 · see citing works
Self-citationFrankel, L. B., Christoffersen, N. R., Jacobsen, A., Lindow, M., Krogh, A., & Lund, A. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707224200 · Cited by 1,141 · see citing works
MicroRNA-21 Targets the Tumor Suppressor Gene Tropomyosin 1 (TPM1)
Zhu, S., Si, M.-L., Wu, H., & Mo, Y.-Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611393200 · Cited by 1,090 · see citing works
Self-citationMicroRNA-21 targets tumor suppressor genes in invasion and metastasis
Zhu, S., Wu, H., Wu, F., Nie, D., Sheng, S., & Mo, Y.-Y. (2008) · Cell Research · doi:10.1038/cr.2008.24 · Cited by 1,051 · see citing works
Self-citationMicroRNA-21 targets tumor suppressor genes in invasion and metastasis
Shuomin, Zhu, Hailong, H., Wu, Fangting, Daotai, Nie, Shijie, Sheng, Yin-Yuan, et al. (2008) · Cell Research · Cited by 831 · see citing works
Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferation
le Sage, C., Nagel, R., Egan, D. A., Schrier, M., Mesman, E. M., Mangiola, A., Anile, C., Maira, G., Mercatelli, N., Ciafrè, S. A., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601790 · Cited by 816 · see citing works
OncomiRs: the discovery and progress of microRNAs in cancers
Cho, W. C. S. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-60 · Cited by 719 · see citing works
A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes
Kent, O. A., & Mendell, J. T. (2006) · Oncogene · doi:10.1038/sj.onc.1209913 · Cited by 715 · see citing works
Mertens‐Talcott, S. U., Chintharlapalli, S. R., Li, X., & Safe, S. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2416 · Cited by 470 · see citing works
Self-citationMicroRNAs and Cell Cycle Regulation
Carleton, M. O., Cleary, M. A., & Linsley, P. S. (2007) · Cell Cycle · doi:10.4161/cc.6.17.4641 · Cited by 343 · see citing works
Regulation of p27Kip1by miRNA 221/222 in Glioblastoma
Gillies, J. K., & Lorimer, I. A. J. (2007) · Cell Cycle · doi:10.4161/cc.6.16.4526 · Cited by 260 · see citing works
Guardavaccaro, D., Corrente, G., Covone, F., Micheli, L., D'Agnano, I., Starace, G., Caruso, M., & Tirone, F. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1797-1815.2000 · Cited by 230 · see citing works
Wang, X. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl068 · Cited by 215 · see citing works
Lim, I. K. (2006) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-006-0080-1 · Cited by 105 · see citing works
Impaired Expression of the Cell Cycle Regulator BTG2 Is Common in Clear Cell Renal Cell Carcinoma
Struckmann, K., Schraml, P., Simon, R., Elmenhorst, K., Mirlacher, M., Kononen, J., & Moch, H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1687 · Cited by 98 · see citing works
Ficazzola, M. (2001) · Carcinogenesis · doi:10.1093/carcin/22.8.1271 · Cited by 94 · see citing works
Expression of the NF-κB-responsive gene BTG2 is aberrantly regulated in breast cancer
Kawakubo, H., Carey, J., Brachtel, E. F., Gupta, V., Green, J. E., Walden, P. D., & Maheswaran, S. (2004) · Oncogene · doi:10.1038/sj.onc.1208008 · Cited by 78 · see citing works
Seifer, D. B., MacLaughlin, D. T., Penzias, A. S., Behrman, H. R., Asmundson, L., Donahoe, P. K., Haning, R. V., & Flynn, S. D. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.3.8445031 · Cited by 69 · see citing works
Expression of B-cell translocation gene 2 protein in normal human tissues
Melamed, J., Kernizan, S., & Walden, P. (2002) · Tissue and Cell · doi:10.1054/tice.2001.0220 · Cited by 58 · see citing works
Manjarrez, M. E., Ocadiz‐Delgado, R., Valle, L., Pacheco, C., Marroquin, A., la Torre, C. D., Selman, M., & Gariglio, P. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1214 · Cited by 51 · see citing works
Olivier, M., Bautista, S., Vallès, H., & Theillet, C. G. (1998) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199809)23:1 · Cited by 24 · see citing works
Transduction of human hepatocellular carcinoma cells with humanγ-interferon geneviaretroviral vector
Qian, S. (1998) · World Journal of Gastroenterology · doi:10.3748/wjg.v4.i3.210 · Cited by 11 · see citing works
Flagged first, then by citations
1 of the 33 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways
Schetter, A. J., Heegaard, N. H. H., & Harris, C. C. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp272 · Cited by 659 · see citing works
Silencing of microRNA families by seed-targeting tiny LNAs
Obad, S., dos Santos, C. O., Petri, A., Heidenblad, M., Broom, O. J., Ruse, C. I., Fu, C., Lindow, M., Stenvang, J., Straarup, E. M., et al. (2011) · Nature Genetics · doi:10.1038/ng.786 · Cited by 627 · see citing works
Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
Hatley, M. E., Patrick, D. M., Garcia, M. R., Richardson, J. A., Bassel-Duby, R., van Rooij, E., & Olson, E. N. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.013 · Cited by 626 · see citing works
“In laryngeal carcinoma, miR-21 targets BTG2 (Liu et al., 2009), a p53 target gene, recently shown to suppress oncogenic Ras activity by reducing the GTP-bound, active state (Buganim et al.”
Zhang, J.-G., Wang, J., Zhao, F., Liu, Q., Jiang, K., & Yang, G. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.02.074 · Cited by 564 · see citing works
MicroRNAs: Potential biomarkers for cancer diagnosis, prognosis and targets for therapy
Cho, W. C. S. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.12.014 · Cited by 487 · see citing works
Apoptosis and the target genes of microRNA-21
Buscaglia, L. E. B., & Li, Y. (2011) · 癌症：英文版 · doi:10.5732/cjc.011.10132 · Cited by 374 · see citing works
Self-citationJiang, S., Zhang, L.-F., Zhang, H.-W., Hu, S. N., Lu, M.-H., Liang, S., Li, B., Li, Y., Li, D., Wang, E.-D., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.45 · Cited by 356 · see citing works
Self-citationMicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitis
Murugaiyan, G., da Cunha, A. P., Ajay, A. K., Joller, N., Garo, L. P., Kumaradevan, S., Yosef, N., Vaidya, V. S., & Weiner, H. L. (2015) · Journal of Clinical Investigation · doi:10.1172/jci74347 · Cited by 239 · see citing works
Traumatic brain injury: classification, models, and markers
Najem, D., Rennie, K., Ribecco‐Lutkiewicz, M., Ly, D., Haukenfrers, J., Liu, Q., Nzau, M., Fraser, D. D., & Bani‐Yaghoub, M. (2018) · Biochemistry and Cell Biology · doi:10.1139/bcb-2016-0160 · Cited by 206 · see citing works
MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2
Chen, H., Pan, H., Qian, Y., Zhou, W., & Liu, X. (2018) · Molecular Cancer · doi:10.1186/s12943-017-0754-0 · Cited by 163 · see citing works
BTG2: A rising star of tumor suppressors (Review)
Mao, B., Zhang, Z., & Wang, G. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2765 · Cited by 160 · see citing works
Boele, J., Persson, H., Shin, J. W., Ishizu, Y., Newie, I., Søkilde, R., Hawkins, S. M., Coarfa, C., Ikeda, K., Takayama, K., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317751111 · Cited by 152 · see citing works
MiR-21: an environmental driver of malignant melanoma?
Melnik, B. C. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0570-5 · Cited by 129 · see citing works
Non-Random Integration of the HPV Genome in Cervical Cancer
Schmitz, M., Driesch, C., Jansen, L., Runnebaum, I. B., & Dürst, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039632 · Cited by 129 · see citing works
MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2
Zhou, L., Liang, X., Zhang, L., Yang, L., Nagao, N., Wu, H., Liu, C., Lin, S., Cai, G., & Liu, J. (2016) · Oncotarget · doi:10.18632/oncotarget.10460 · Cited by 128 · see citing works
Self-citationLauschke, V. M., Vorrink, S. U., Moro, S. M. L., Rezayee, F., Nordling, Å., Hendriks, D. F. G., Bell, C. C., Sison‐Young, R., Park, B. K., Goldring, C. E., et al. (2016) · Hepatology · doi:10.1002/hep.28780 · Cited by 113 · see citing works
MiR-101 regulates HSV-1 replication by targeting ATP5B
Zheng, S., Li, Y., Zhang, Y., Li, X., & Tang, H. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.01.008 · Cited by 117 · see citing works
Self-citationPepsin promotes proliferation of laryngeal and pharyngeal epithelial cells
Johnston, N., Yan, J. C., Hoekzema, C. R., Samuels, T. L., Stoner, G. D., Blumin, J. H., & Bock, J. M. (2012) · The Laryngoscope · doi:10.1002/lary.23307 · Cited by 115 · see citing works
Foxo3a Regulates Apoptosis by Negatively Targeting miR-21
Wang, K., & Li, P.-F. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.093005 · Cited by 114 · see citing works
A multi-targeted approach to suppress tumor-promoting inflammation
Samadi, A. K., Bilsland, A. E., Georgakilas, A. G., Amedei, A., Amin, A., Bishayee, A., Azmi, A. S., Lokeshwar, B. L., Grue, B., Panis, C., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.006 · Cited by 113 · see citing works
Fix, L. N., Shah, M., Efferth, T., Farwell, M. A., & Zhang, B. (2010) · PubMed · Cited by 110 · see citing works
Regulation of Breast Cancer and Bone Metastasis by MicroRNAs
Vimalraj, S., Miranda, P. J., Ramyakrishna, B., & Selvamurugan, N. (2013) · Disease Markers · doi:10.1155/2013/451248 · Cited by 108 · see citing works
Coppola, V., Musumeci, M., Patrizii, M., Cannistraci, A., Addario, A., Maugeri‐Saccà, M., Biffoni, M., Francescangeli, F., Cordenonsi, M., Piccolo, S., et al. (2012) · Oncogene · doi:10.1038/onc.2012.194 · Cited by 106 · see citing works
Circulating MicroRNA-21 Is a Potential Diagnostic Biomarker in Gastric Cancer
Wu, J., Li, G., Wang, Z., Yao, Y., Chen, R., Pu, X.-Y., & Wang, J. (2015) · Disease Markers · doi:10.1155/2015/435656 · Cited by 102 · see citing works
MicroRNA-21: a therapeutic target for reversing drug resistance in cancer
Hong, L., Han, Y., Zhang, Y., Zhang, H., Zhao, Q., Wu, K., & Fan, D. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.819853 · Cited by 103 · see citing works
MiR-21 Protected Cardiomyocytes against Doxorubicin-Induced Apoptosis by Targeting BTG2
Tong, Z., Jiang, B., Wu, Y., Liu, Y., Li, Y., Gao, M., Jiang, Y., Lv, Q., & Xiao, X. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160714511 · Cited by 102 · see citing works
Self-citationComprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma
Cao, P., Zhou, L., Zhang, J., Zheng, F., Wang, H., Ma, D., & Tian, J. (2012) · Head & Neck · doi:10.1002/hed.23011 · Cited by 102 · see citing works
Relevance of miR-21 in regulation of tumor suppressor gene PTEN in human cervical cancer cells
Peralta-Zaragoza, Ó., Deas, J., Meneses‐Acosta, A., De-la-O-Gómez, F., Fernández‐Tilapa, G., Gómez-Cerón, C., Benítez-Boijseauneau, O., Burguete-García, A. I., Torres-Poveda, K., Bermúdez-Morales, V. H., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2231-3 · Cited by 102 · see citing works
Regulation of cancer metastasis by cell-free miRNAs
Alečković, M., & Kang, Y. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.10.005 · Cited by 100 · see citing works
Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma
Sand, M. S., Skrygan, M., Georgas, D., Sand, D., Hahn, S. A., Gambichler, T., Altmeyer, P. J., & Bechara, F. G. (2012) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2012.09.004 · Cited by 99 · see citing works
Sakai, A., & Suzuki, H. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.04.089 · Cited by 97 · see citing works
Lopatina, T., Gai, C., Deregibus, M. C., Kholia, S., & Camussi, G. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00125 · Cited by 98 · see citing works
MicroRNA-21 regulates T-cell apoptosis by directly targeting the tumor suppressor gene Tipe2
Ruan, Q., Wang, P., Wang, T., Qi, J., Wei, M. H., Wang, S., Fan, T., Johnson, D., Wan, X., Shi, W., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.47 · Cited by 92 · see citing works
Bian, K., Fan, J., Zhang, X., Yang, X., Zhu, H., Wang, L., Sun, J., Meng, Y., Cui, P., Cheng, S.-Y., et al. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.01.050 · Cited by 84 · see citing works
Cao, M., Zhao, Y., Chen, T., Zhao, Z., Zhang, B., Yuan, C., Wang, X., Chen, L., Wang, N., Li, C., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121739 · Cited by 82 · see citing works
Ou, H., Li, Y., & Kang, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109929 · Cited by 78 · see citing works
Self-citationStrategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury
Lee, T. J., Yuan, X., Kerr, K. M., Yoo, J. Y., Kim, D., Kaur, B., & Eltzschig, H. K. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.019026 · Cited by 78 · see citing works
Nedaeinia, R., Sharifi, M., Avan, A., Kazemi, M., Rafiee, L., Ghayour‐Mobarhan, M., & Salehi, R. (2016) · Cancer Gene Therapy · doi:10.1038/cgt.2016.25 · Cited by 76 · see citing works
MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases
Li, S., Liang, Z., Liu, X., & Zou, F. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1052-6 · Cited by 76 · see citing works
Galangin suppresses human laryngeal carcinoma via modulation of caspase-3 and AKT signaling pathways
Wang, H., & Tang, C. (2017) · Oncology Reports · doi:10.3892/or.2017.5767 · Cited by 72 · see citing works
Wang, F., Song, G., Liu, M., Li, X., & Tang, H. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.08.052 · Cited by 70 · see citing works
Self-citationLin, H., Shi, X., Li, H., Hui, J., Liu, R., Chen, Z., Lu, Y., & Tan, W. (2021) · BMC Cancer · doi:10.1186/s12885-021-08926-x · Cited by 65 · see citing works
MicroRNAs in Head and Neck Squamous Cell Carcinoma (HNSCC) and Oral Squamous Cell Carcinoma (OSCC)
Shiiba, M., Uzawa, K., & Tanzawa, H. (2010) · Cancers · doi:10.3390/cancers2020653 · Cited by 65 · see citing works
Hsa-miR-34c suppresses growth and invasion of human laryngeal carcinoma cells via targeting c-Met
Cai (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000378 · Cited by 63 · see citing works
Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma
Hou, B., Ishinaga, H., Midorikawa, K., Shah, S. A., Nakamura, S., Hiraku, Y., Oikawa, S., Murata, M., & Takeuchi, K. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1045692 · Cited by 61 · see citing works
Role of Inflammation and Oxidative Stress Mediators in Gliomas
Conti, A., Gulì, C., Torre, D. L., Tomasello, C., Angileri, F. F., & Aguennouz, M. (2010) · Cancers · doi:10.3390/cancers2020693 · Cited by 61 · see citing works
Li, W., Ma, H., & Sun, J. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.1929 · Cited by 59 · see citing works
The BTG2-PRMT1 module limits pre-B cell expansion by regulating the CDK4-Cyclin-D3 complex
Dolezal, E., Infantino, S., Drepper, F., Börsig, T., Singh, A., Wossning, T., Fiala, G. J., Minguet, S., Warscheid, B., Tarlinton, D. M., et al. (2017) · Nature Immunology · doi:10.1038/ni.3774 · Cited by 57 · see citing works
Yu, W., Zhu, K., Wang, Y., Yu, H., & Guo, J. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0034-5 · Cited by 57 · see citing works
Mullenbrock, S., Shah, J., & Cooper, G. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.274076 · Cited by 56 · see citing works
Tat RNA silencing suppressor activity contributes to perturbation of lymphocyte miRNA by HIV-1
Hayes, A. M., Qian, S., Yu, L., & Boris‐Lawrie, K. (2011) · Retrovirology · doi:10.1186/1742-4690-8-36 · Cited by 55 · see citing works
Hegazy, M., Elkady, M. A., Yehia, A. M., Elsakka, E. G. E., Abulsoud, A. I., Abdelmaksoud, N. M., Elshafei, A., Abdelghany, T. M., Elkhawaga, S. Y., Ismail, A., et al. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154510 · Cited by 55 · see citing works
MicroRNA-21 expression is associated with overall survival in patients with glioma
Wu, L., Li, G., Feng, D., Qin, H., Gong, L., Zhang, J., & Zhang, Z. (2013) · Diagnostic Pathology · doi:10.1186/1746-1596-8-200 · Cited by 53 · see citing works
Abtin, M., Alivand, M. R., Khaniani, M. S., Bastami, M., Zaeifizadeh, M., & Derakhshan, S. M. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26754 · Cited by 52 · see citing works
Targeting miR-21 in glioma: a small RNA with big potential
Moore, L. M., & Zhang, W. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.527334 · Cited by 51 · see citing works
BLIMP-1 and STAT3 Counterregulate MicroRNA-21 during Plasma Cell Differentiation
Barnes, N. A., Stephenson, S., Cocco, M., Tooze, R. M., & Doody, G. M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101563 · Cited by 50 · see citing works
miR-21: A gene of dual regulation in breast cancer
Zhang, C., Liu, K., LI, T., Fang, J., Ding, Y., Sun, L., TU, T., JIANG, X., Du, S., Hu, J., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3232 · Cited by 50 · see citing works
MicroRNAs in laryngeal cancer: implications for diagnosis, prognosis and therapy.
Li, P., Liu, H., Wang, Z., He, F., Wang, H., Shi, Z., Yang, A., & Ye, J. (2016) · PubMed Central · Cited by 50 · see citing works
Zhong, Z., Dong, Z., Yang, L., & Gong, Z. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1287-y · Cited by 48 · see citing works
miR-21 expression predicts prognosis in hepatocellular carcinoma
Wang, W., Zhang, H.-F., Wang, L., Ma, Y., Gao, F., Zhang, S., & Wang, L. (2014) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2014.07.001 · Cited by 46 · see citing works
Effects of BTG2 on proliferation inhibition and anti-invasion in human lung cancer cells
Wei, S., Hao, C., Li, X., Zhao, H., Chen, J., & Zhou, Q. (2012) · Tumor Biology · doi:10.1007/s13277-012-0370-y · Cited by 45 · see citing works
Self-citationPiotrowski, I., Zhu, X., Saccon, T. D., Ashiqueali, S., Schneider, A., Nunes, A. D. D. C., Noureddine, S. A., Sobecka, A., Barczak, W., Szewczyk, M. P., et al. (2021) · Cancers · doi:10.3390/cancers13163980 · Cited by 45 · see citing works
MicroRNAs in Liver Regeneration
Chen, X., Zhao, Y., Wang, F., Bei, Y., Xiao, J., & Yang, C. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430381 · Cited by 44 · see citing works
Self-citationDown-regulation of BTG1 by miR-454-3p enhances cellular radiosensitivity in renal carcinoma cells
Wu, X., Ding, N., Hu, W., He, J., Xu, S., Pei, H., Hua, J., Zhou, G., & Wang, J. (2014) · Radiation Oncology · doi:10.1186/1748-717x-9-179 · Cited by 44 · see citing works
Insight toward the MicroRNA Profiling of Laryngeal Cancers: Biological Role and Clinical Impact
Takeuchi, T., Kawasaki, H., Luce, A., Cossu, A. M., Misso, G., Scrima, M., Bocchetti, M., Ricciardiello, F., Caraglia, M., & Zappavigna, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103693 · Cited by 43 · see citing works
Choi, J.-A., Jung, Y. S., Kim, J. Y., Kim, H. M., & Lim, I. K. (2015) · Oncogene · doi:10.1038/onc.2015.64 · Cited by 42 · see citing works
Vychytilova‐Faltejskova, P., Bešše, A., Ševčı́ková, S., Kubiczková, L., Svoboda, M., Šmarda, J., Kišš, I., Vyzula, R., & Slabý, O. (2012) · International Journal of Colorectal Disease · doi:10.1007/s00384-012-1461-3 · Cited by 42 · see citing works
MicroRNA-21 Down-regulates Rb1 Expression by Targeting PDCD4 in Retinoblastoma
Shen, F., Mo, M.-H., Chen, L., An, S., Tan, X., Fu, Y., Rezaei, K., Wang, Z., Zhang, L., & Fu, S. W. (2014) · Journal of Cancer · doi:10.7150/jca.10456 · Cited by 42 · see citing works
Wang, L., Yu, J., Xu, J., Zheng, C., Li, X., & Du, J. (2014) · Gene · doi:10.1016/j.gene.2014.10.032 · Cited by 41 · see citing works
Self-citationmicroRNAs as novel epigenetic biomarkers for human cancer
Cortés-Sempere, M., & de Cáceres, I. I. (2011) · Clinical & Translational Oncology · doi:10.1007/s12094-011-0668-z · Cited by 40 · see citing works
Re, M., Magliulo, G., Gioacchini, F. M., Bajraktari, A., Bertini, A., Çeka, A., Rubini, C., Ferrante, L., Procopio, A. D., & Olivieri, F. (2017) · BioMed Research International · doi:10.1155/2017/3921258 · Cited by 40 · see citing works
MicroRNA-21 regulates the expression of BTG2 in HepG2 liver cancer cells
Mao, B., Xiao, H., Zhang, Z., Wang, D., & Wang, G. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4051 · Cited by 39 · see citing works
Urinary metabolomics for discovering metabolic biomarkers of laryngeal cancer using UPLC-QTOF/MS
Chen, J., Hou, H., Chen, H., Luo, Y.-B., Zhang, L., Zhang, Y., Liu, H., Zhang, F., Liu, Y., Wang, A., et al. (2019) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2019.01.035 · Cited by 39 · see citing works
Dai, M., FANG, F., Zou, Y., Yi, X., Ding, Y.-J., Chen, C., Tao, Z., & Chen, S. (2015) · Oncology Reports · doi:10.3892/or.2015.4274 · Cited by 37 · see citing works
Shen, S., Zhang, R., Guo, Y., Loehrer, E. A., Wei, Y., Zhu, Y., Yuan, Q., Morán, S., Fleischer, T., Bjaanæs, M. M., et al. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12204 · Cited by 37 · see citing works
RNA-directed repair of DNA double-strand breaks
Yang, Y., & Qi, Y. (2015) · DNA repair · doi:10.1016/j.dnarep.2015.04.017 · Cited by 36 · see citing works
Zhang, Y., Wei, L., Liu, M., Li, J., Zheng, Y., Gao, Y., & Li, X. (2013) · Tumor Biology · doi:10.1007/s13277-013-0691-5 · Cited by 36 · see citing works
Self-citationmicro RNA deregulation in keloids: an opportunity for clinical intervention?
Yu, X., Li, Z., Chan, M. T. V., & Wu, W. K. K. (2015) · Cell Proliferation · doi:10.1111/cpr.12225 · Cited by 34 · see citing works
Chen, G., Gou, B., Du, Y., Zhou, Z., Bai, Y., Yang, Y., Nan, Y., & Yuan, L. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156892 · Cited by 33 · see citing works
Shen, N., Huang, X., & Li, J. (2015) · Tumor Biology · doi:10.1007/s13277-015-3969-y · Cited by 33 · see citing works
MiR‐613 suppressed the laryngeal squamous cell carcinoma progression through regulating PDK1
Wang, J., Yang, S., Ge, W., Wang, Y., Han, C., & Li, M. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26468 · Cited by 33 · see citing works
Dynamic Single Molecular Rulers: Toward Quantitative Detection of MicroRNA-21 in Living Cells
Li, M., Zhao, W., Wang, H., Li, X., Xu, C.-H., Chen, H., & Xu, J. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b03322 · Cited by 33 · see citing works
Self-citationMüller, S., Wedler, A., Breuer, J., Glaß, M., Bley, N., Lederer, M., Haase, J., Misiak, C., Fuchs, T., Ottmann, A., et al. (2020) · NAR Cancer · doi:10.1093/narcan/zcaa014 · Cited by 33 · see citing works
Biomarkers in Laryngeal Squamous Cell Carcinoma: The Literature Review
Verro, B., Saraniti, C., Carlisi, D., Chiesa-Estomba, C. M., Maniaci, A., Lechien, J. R., Mayo‐Yáñez, M., Fakhry, N., & Lauricella, M. (2023) · Cancers · doi:10.3390/cancers15205096 · Cited by 32 · see citing works
MicroRNA‐16 targets zyxin and promotes cell motility in human laryngeal carcinoma cell line HEp‐2
Wu, H., Liu, T., Wang, R., Tian, S., Liu, M., Li, X., & Tang, H. (2011) · IUBMB Life · doi:10.1002/iub.417 · Cited by 32 · see citing works
Self-citationNedaeinia, R., Avan, A., Ahmadian, M., Nia, S. N., Ranjbar, M., Sharifi, M., Goli, M., Piroozmand, A., Nourmohammadi, E., Manian, M., et al. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26047 · Cited by 32 · see citing works
Zhang, Z., Chen, C., Wang, G., Yang, Z., San, J.-L., Zheng, J., Li, Q., Luo, X.-Z., Hu, Q., Li, Z., et al. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9164-x · Cited by 30 · see citing works
Ferroptosis and oral squamous cell carcinoma: connecting the dots to move forward
Antonelli, A., Battaglia, A. M., Sacco, A., Petriaggi, L., Giorgio, E., Barone, S., Biamonte, F., & Giudice, A. (2024) · Frontiers in Oral Health · doi:10.3389/froh.2024.1461022 · Cited by 29 · see citing works
Zou, Y., Fang, F., Ding, Y.-J., Dai, M., Yi, X., Chen, C., Tao, Z., & Chen, S. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5688 · Cited by 28 · see citing works
Seno, A., Kasai, T., Ikeda, M., Vaidyanath, A., Masuda, J., Mizutani, A., Murakami, H., Ishikawa, T., & Seno, M. (2016) · Cancer Informatics · doi:10.4137/cin.s39839 · Cited by 28 · see citing works
Wang, R. Y., Zhu, H., Yang, M., & Zhu, C. (2019) · Oncology Letters · doi:10.3892/ol.2019.10931 · Cited by 27 · see citing works
Platelet miRNAs and cardiovascular diseases
Eduardo Fuentes, Q., Palomo, I. F., & Alarcón, M. A. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.04.016 · Cited by 27 · see citing works
microRNAs are important players in head and neck carcinoma: A review
Janiszewska, J., Szaumkessel, M., & Szyfter, K. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.07.012 · Cited by 26 · see citing works
Li, X., Huang, K., & Yu, J. (2014) · Oncology Letters · doi:10.3892/ol.2014.2066 · Cited by 26 · see citing works
Self-citationLiu, C., Liu, H., Wen, Y., Huang, H., Hao, J., Lv, Y., Qin, R., & Yang, X. (2019) · Molecules · doi:10.3390/molecules24061074 · Cited by 25 · see citing works
CD24: A Novel Cancer Biomarker in Laryngeal Squamous Cell Carcinoma
Shi, Y., Gong, H.-L., Zhou, L. F., Tian, J., & Wang, Y. (2012) · ORL · doi:10.1159/000335584 · Cited by 24 · see citing works
Wang, W., Lin, X., Pu, Q.-H., Liu, M.-Y., Li, L., Wu, L., Wu, Q., Mao, J., Zhu, J., & Jin, X. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.10.107 · Cited by 24 · see citing works
Self-citationMiR-154 inhibits the growth of laryngeal squamous cell carcinoma by targeting GALNT7
Niu, J., Zhang, L.-J., Huang, Y., Li, C., Jiang, N., & Niu, Y. (2018) · Biochemistry and Cell Biology · doi:10.1139/bcb-2018-0047 · Cited by 23 · see citing works
RetractedExpression and significance of miRNA-21 and BTG2 in lung cancer
Sun, Q., Hang, M., Guo, X., Shao, W., & Zeng, G. (2013) · Tumor Biology · doi:10.1007/s13277-013-0992-8 · Cited by 23 · see citing works
Lung Cancer Cells Derived Circulating miR-21 Promotes Differentiation of Monocytes into Osteoclasts
Zhao, Q., Liu, C., Xie, Y., Tang, M., Luo, G., Chen, X., Tian, L., & Yu, X. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s232876 · Cited by 22 · see citing works
- Authors
- Liu, M., Wu, H., Liu, T., Li, Y., Wang, F., Wan, H., Li, X., & Tang, H.
- Affiliations
- Tianjin Medical University (CN)
- Corresponding author
- Tang, Hua
- Venue
- Cell Research
- Published
- 2009-06-23
- Volume
- 19
- Issue
- 7
- Pages
- 828-837
- ISSN
- 1001-0602 (ISSN-L)
- 1748-7838
- OpenAlex
- W2083966895
- Cited by
- 189
- References
- 33
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 7 · 2023: 6 · 2022: 6 · 2021: 18 · 2020: 11 · 2019: 4 · 2018: 11 · 2017: 10 · 2016: 14 · 2015: 20 · 2014: 20 · 2013: 8 · 2012: 14
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cell Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (30873017)
- Tianjin Medical University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Keywords
- miR-21, BTG2, laryngeal cancer, miRNA target genes, cell cycle regulation, G1/S transition, tumor suppressor, cell proliferation, HEp-2 cells, post-transcriptional regulation, oncogenic microRNA
- MeSH terms
- Carcinoma, Humans, Laryngeal Neoplasms, Down-Regulation, Gene Expression Regulation, Neoplastic, G1 Phase, S Phase, Oligonucleotides, Antisense, Immediate-Early Proteins, Tumor Suppressor Proteins, MicroRNAs, Cell Line, Tumor, Gene Knockdown Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
